NFAT5 and hepatocellular carcinoma: Qin et al. (2017) illustrated that HBV induced hypermethylation of the AP1-binding site in the NFAT5 promoter in hepatoma cells, and suppression of NFAT5 may lead to reduced apoptosis of hepatoma cells [38].